A Study of AK-01 (LY3295668) in Solid Tumors

Clinical trial NCT03092934 · COMPLETED

Trial details

NCT number: NCT03092934
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Neoplasms Neoplasm Metastasis Triple Negative Breast Neoplasms Head and Neck Neoplasms Breast Neoplasms Solid Tumor, Adult Small Cell Lung Carcinoma

Start date: 2017-05-29
Primary completion: 2020-04-20
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.